An anti-NCL antibody inhibited EVA71 binding to cells, and NCL knockdown by RNA interference decreased EVA71 binding, infection, and production in human cells demonstrating unequivocally that NCL is a co-receptor for EVA71 [36]. The gene discussed is NUCLEOLIN; the disease is infection.